Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jean-Louis Houpeau"'
Autor:
Hélène Viruega, Corinne Galy, Célia Loriette, Stéphane Jacquot, Jean Louis Houpeau, Manuel Gaviria
Publikováno v:
Cancers; Volume 15; Issue 4; Pages: 1317
Background: Breast cancer is the most diagnosed women’s cancer with a high survival rate nowadays. Because cancer is a systemic disease characterized by variable course, heterogeneity and unequal environmental inputs, disparities in the persons’
Autor:
Sylvia Giard, Cécile Bendavid-Athias, Marie-Pierre Chauvet, H. Charitansky, Andrew Kramar, Jean-Louis Houpeau, François Guillemin
Publikováno v:
Journal of Surgical Oncology. 113:501-507
Background and Objectives The French Sentimag feasibility trial evaluated a new method for the localization of breast cancer sentinel lymph node (SLN) using Sienna+®, superparamagnetic iron oxide particles, and Sentimag® detection in comparison to
Autor:
Jean-Louis, Houpeau, Marie-Pierre, Chauvet, François, Guillemin, Cécile, Bendavid-Athias, Hélène, Charitansky, Andrew, Kramar, Sylvia, Giard
Publikováno v:
Journal of surgical oncology. 113(5)
The French Sentimag feasibility trial evaluated a new method for the localization of breast cancer sentinel lymph node (SLN) using Sienna+®, superparamagnetic iron oxide particles, and Sentimag® detection in comparison to the standard technique (is
Autor:
Emmanuelle Tresch, Ninad Katdare, Jean-Pierre Meurant, Jean-Louis Houpeau, Lucie Bresson, Sophie El Bedoui, Henri Azaïs, Fabrice Narducci, Benjamin Merlot, Alfred Bassil
Publikováno v:
The journal of vascular access. 16(1)
Purpose Totally implantable venous access port systems (TIVAPS) are a widely used and an essential tool in the efficient delivery of chemotherapy. Chemotherapy drug extravasation (CDE) can have dire consequences and will delay treatment. The purpose
Autor:
Marie-Astrid, Carillon, Sylvia, Giard, Virginie, Emmanuelli, Jean-Louis, Houpeau, Luc, Ceugnart, Marie-Pierre, Chauvet
Publikováno v:
Bulletin du cancer. 99(2)
On March 30, 2010, Afssaps issued a health alert concerning breast implants brand PIP, after identifying a rupture rate higher than for other manufacturers. This alert asking the recall of all concerned patients with, according to the clinical examin